Title : Ofatumumab in the treatment of low-grade non-Hodgkin's lymphomas and chronic lymphocytic leukemia.

Pub. Date : 2011 May

PMID : 21595596






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ofatumumab is a novel anti-CD20 monoclonal antibody recently approved for the treatment of chronic lymphocytic leukemia refractory to alemtuzumab and fludarabine. fludarabine keratin 20 Homo sapiens